semaglutide and palpitations What is the effect of (Glucagon-like peptide-1 (GLP-1) receptor agonist) on heart rate, specifically tachycardia? GLP-1 Heart Palpitations: Safety, Causes

JAMA network open , 8 (1), e2457349

Relax and Unwind : During most treatments, you can read, work on your laptop, check emails, or even take a nap

For eating disorder patients, non-pharmacological approachessuch as dialectical behavior therapy (DBT)provide sustainable tools without appetite suppression risks

Genetic insight transforms weight gain during treatment from a mystery into a data-driven optimization opportunity

In the SURPASS-4 trial, patients receiving tirzepatide experienced an average weight loss of 7.1 kg (15.7 lbs) after 52 weeks, compared to 2.5 kg (5.5 lbs) in the insulin glargine group[6]

Here are scenarios where staying on tirzepatide, adjusting the current protocol, or exploring other options makes more sense than switching to retatrutide